Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy.
Blauvelt A, Chen Y, Branigan PJ, Liu X, DePrimo S, Keyes BE, Leung M, Fakharzadeh S, Yang YW, Muñoz-Elías EJ, Krueger JG, Langley RG. Blauvelt A, et al. Among authors: fakharzadeh s. JID Innov. 2024 Jun 26;4(5):100297. doi: 10.1016/j.xjidi.2024.100297. eCollection 2024 Sep. JID Innov. 2024. PMID: 39224116 Free PMC article.
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Blauvelt A, Gordon KB, Langley RG, Branigan PJ, Chen Y, Miller M, Han C, Fakharzadeh S, Muñoz-Elías EJ, Armstrong AW. Blauvelt A, et al. Among authors: fakharzadeh s. J Invest Dermatol. 2024 Dec;144(12):2816-2819.e2. doi: 10.1016/j.jid.2024.05.020. Epub 2024 Jun 25. J Invest Dermatol. 2024. PMID: 38936766 Free article. No abstract available.
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.
Krueger JG, Eyerich K, Kuchroo VK, Ritchlin CT, Abreu MT, Elloso MM, Fourie A, Fakharzadeh S, Sherlock JP, Yang YW, Cua DJ, McInnes IB. Krueger JG, et al. Among authors: fakharzadeh s. Front Immunol. 2024 Apr 15;15:1331217. doi: 10.3389/fimmu.2024.1331217. eCollection 2024. Front Immunol. 2024. PMID: 38686385 Free PMC article. Review.
Effect of Partial or Complete Replacement of Dietary Inorganic Trace Minerals Supplement with an Advanced Chelated Source on Nutrient Digestibility in Sheep.
Rajaei-Sharifabadi H, Shokri Z, Rohollahi M, Yari M, Fakharzadeh S, Kalanaky S, Nazaran MH, de la Fuente Oliver G, Seradj AR. Rajaei-Sharifabadi H, et al. Among authors: fakharzadeh s. Animals (Basel). 2024 Nov 6;14(22):3182. doi: 10.3390/ani14223182. Animals (Basel). 2024. PMID: 39595234 Free PMC article.
Beneficial effects of advanced chelate technology-based 7-minerals in aflatoxin-B1 challenged broilers: toxin residue reduction, serum biochemical improvement and modulation of the mRNA expression of NF-kB and Nrf2, and genes within their pathways.
Mohammadi Z, Taherpour K, Ghasemi HA, Fakharzadeh S, Nooreh Z, Kalanaky S. Mohammadi Z, et al. Among authors: fakharzadeh s. J Sci Food Agric. 2024 Dec;104(15):9324-9335. doi: 10.1002/jsfa.13755. Epub 2024 Jul 23. J Sci Food Agric. 2024. PMID: 39041368
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.
Hafizi M, Kalanaky S, Fakharzadeh S, Karimi P, Fakharian A, Lookzadeh S, Mortaz E, Mirenayat MS, Heshmatnia J, Karam MB, Zamani H, Nadji A, Toutkaboni MP, Oraee-Yazdani S, Akbari ME, Jamaati H, Nazaran MH. Hafizi M, et al. Among authors: fakharzadeh s. Trials. 2023 Nov 11;24(1):720. doi: 10.1186/s13063-023-07624-2. Trials. 2023. PMID: 37951972 Free PMC article. Clinical Trial.
Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses.
Kalanaky S, Fakharzadeh S, Karimi P, Hafizi M, Jamaati H, Hassanzadeh SM, Khorasani A, Mahdavi M, Nazaran MH. Kalanaky S, et al. Among authors: fakharzadeh s. Viral Immunol. 2023 Jul-Aug;36(6):409-423. doi: 10.1089/vim.2023.0001. Epub 2023 Jul 28. Viral Immunol. 2023. PMID: 37506342
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study.
Kimball AB, Podda M, Alavi A, Miller M, Shen YK, Li S, Xu Y, Han C, Fakharzadeh S, Yang YW, DePrimo S, Munoz E, Chen Y, Passeron T, Papp K. Kimball AB, et al. Among authors: fakharzadeh s. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):2098-2108. doi: 10.1111/jdv.19252. Epub 2023 Jun 27. J Eur Acad Dermatol Venereol. 2023. PMID: 37317022 Clinical Trial.
79 results